Difference between revisions of "Team:TECHNION-ISRAEL/example 2"

(Blanked the page)
 
(37 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{:Team:TECHNION-ISRAEL/home_2}}
 
<html lang="en">
 
<head>
 
<!-- Title for the page & metadata  -->       
 
<title>HP</title>
 
<meta charset="utf-8">
 
 
 
</head>
 
<body>
 
 
<div class= "container">
 
 
<div class= "row">
 
<h1> Human Practices </h1>
 
<img src="https://static.igem.org/mediawiki/2017/9/9d/T--TECHNION-ISRAEL--HP.png" class="cover" alt="" style= " width:120% ;" <>
 
<br>
 
</div>
 
 
 
<div class = "row">
 
<div class= "col-md-offset-1 col-md-10">
 
<h3 id="hello 5"> Socioeconomic Periphery </h3>
 
<br>
 
<p> We set out to create a preventative treatment for allergies and autoimmune disease by utilizing the innate mechanism of Central Tolerance. We’ve designed a modular plasmid based platform that will allow for inducible expression, and display, of target antigens on the membrane of Hematopoietic Stem Cells (HSCs). In our project, murine Hematopoietic Progenitor Cells (HPC-7) were used as a model for HSCs and transfected with our plasmid. Additionally, we attempted to show apoptosis in an immature B cell model (WEHI-231) as a result of our treatment, closely approximating the process of Central Tolerance. In the future this technology may be used to engineer HSCs harvested from cord blood and allow for a cost effective preventative treatment.
 
</p>
 
<img src="https://static.igem.org/mediawiki/2017/b/b0/T--TECHNION-ISRAEL--cover.png" class="graphs" alt="" >
 
<img src="https://static.igem.org/mediawiki/2017/b/b0/T--TECHNION-ISRAEL--cover.png" class="graphs" alt="" >
 
</div>
 
</div>
 
 
<br>
 
<br>
 
 
<div class = "row">
 
<div class= "col-md-offset-1 col-md-6">
 
<h3 id="hello 2"> Run for Tolerance </h3>
 
</div>
 
</div>
 
<br>
 
<br>
 
  
</div>
 
</body>
 
</html>
 
 
{{:Team:TECHNION-ISRAEL/example}}
 

Latest revision as of 02:03, 2 November 2017